Dr. Nehal Lakhani, MD
Claim this profileSTART Midwest
About Nehal Lakhani, MD
Education:
Graduated from Maharaja Sayajirao University-Baroda Medical College, India in 2000.
Earned a Ph.D. in Pharmaceutical Sciences (Pharmacokinetics) from the National Institutes of Health – Medical College of Virginia Graduate Partnerships Program.
Completed Residency in Internal Medicine at Michigan State University.
Undertook a Fellowship in Hematology/Oncology at the National Cancer Institute/National Institutes of Health.
Experience:
Board certified in Internal Medicine, Medical Oncology, and Hematology.
Currently the Director of Clinical Research at START Midwest and a Medical Oncologist in Grand Rapids, Michigan.
Authored and co-authored over 90 peer-reviewed publications.
Member of professional organizations such as ASCO, AACR, and SITC.
Area of expertise
Lung Cancer
Nehal Lakhani, MD has run 11 trials for Lung Cancer. Some of their research focus areas include:
Solid Tumors
Nehal Lakhani, MD has run 10 trials for Solid Tumors. Some of their research focus areas include:
Affiliated Hospitals
START Midwest
South Texas Accelerated Research Therapeutics Midwest
Clinical Trials Nehal Lakhani, MD is currently running
LY4066434
for Solid Tumors
The main purpose of the study is to assess whether the study drug, LY4066434, is safe and tolerable when administered to participants with locally advanced or metastatic solid tumors with certain KRAS mutations. LY4066434 will be given alone or in combination with other treatments. The study will have 2 parts: monotherapy dose escalation and dose optimization. The study is expected to last up to approximately 5 years.
Recruiting
1 award
Phase 1
4 criteria
SGN-CEACAM5C
for Advanced Cancers
This trial is testing a new drug called SGN-CEACAM5C for patients with hard-to-treat solid tumors that have either returned or didn't respond to standard treatments. The drug targets cancer cells and kills them. The study will determine the safe dosage and effectiveness of the drug.
Recruiting
1 award
Phase 1
7 criteria
More about Nehal Lakhani, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 25 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Nehal Lakhani, MD has experience with
- Sym021
- Sym022
- Sym023
- Irinotecan Hydrochloride
- Sym024
- Upifitamab Rilsodotin
Breakdown of trials Nehal Lakhani, MD has run
Solid Tumors
Pancreatic Cancer
Cancer
- CC-94676 for Metastatic Castration-Resistant Prostate Cancer
- APG-1387 in Patients With Advanced Solid Tumors or Hematologic Malignancies
- Sym021 Monotherapy, in Combination With Sym022 or Sym023, and in Combination With Both Sym022 and Sym023 in Patients With Advanced Solid Tumor Malignancies or Lymphomas
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nehal Lakhani, MD specialize in?
Nehal Lakhani, MD focuses on Lung Cancer and Solid Tumors. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Nehal Lakhani, MD currently recruiting for clinical trials?
Yes, Nehal Lakhani, MD is currently recruiting for 6 clinical trials in Grand Rapids Michigan. If you're interested in participating, you should apply.
Are there any treatments that Nehal Lakhani, MD has studied deeply?
Yes, Nehal Lakhani, MD has studied treatments such as Sym021, Sym022, Sym023.
What is the best way to schedule an appointment with Nehal Lakhani, MD?
Apply for one of the trials that Nehal Lakhani, MD is conducting.
What is the office address of Nehal Lakhani, MD?
The office of Nehal Lakhani, MD is located at: START Midwest, Grand Rapids, Michigan 49546 United States. This is the address for their practice at the START Midwest.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.